|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and tolerabili- ty of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention:a randomised, double-blind, placebocontrolled phase Ⅱ study 显示文摘 | Becker RC Molitemo DJ Jennings LK | 2009 | Lancet2009，373，： | 1 |
| 2 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent pereutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study 显示文摘 | BECKER RC MOLITERNO DJ JENNINGS LK | 2009 | Lancet2009，373，9667： | 1 |
| 3 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention : a randomised, double-blind, placebo-controlled phase II study显示文摘 | Becker RC Moliterno D J Jennings LK | 2009 | Lancet2009，373，9667： | 1 |
| 4 | Risk of early closed reduction in cervical spine subluxation injuries 显示文摘 | Gerald AG Sohail KM Jens RC | 1999 | J Neurosurg1999，90，1： | 1 |
| 5 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase Ⅱ study 显示文摘 | Becker RC Moliterno DJ Jennings LK | 2009 | Lancet2009，373，9667： | 1 |
| 6 | Cytokines as endogenous growth regulators in the alage Ecclesia and Hype 显示文摘 | Jennings RC | 1969 | Austral J Biol Sic1969，22，3： | 1 |
| 7 | Antiplatelet therapy in acute coronary syndrome(ACS):applying new science to clinical decisions显示文摘 | Becker RC Gibson CM Jennings LK | 2010 | Am J Cardiol2010，106，8： | 1 |
| 8 | Safety and tolerabili- ty of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention 显示文摘 | Becket RC Moliterno D J Jennings LK | 2009 | Lancet2009，373，9667： | 1 |
| 9 | Antiplatelet therapy in acute coronary syndrome (acs): Applying new science to clinical decisions显示文摘 | Becker RC Gibson CM Jennings LK Morrow DA | 2010 | Am J Cardiol2010，106，： | 1 |
| 10 | Antiplalele, t therapy in acute coronary syndrome (ACS) : applying new science to clinical decisions 显示文摘 | Becker RC Gibson CM Jennings LK | 2010 | Am J Cardiol2010，106，8： | 1 |
| 11 | Heart rate variability in depressed elderly显示文摘 | Jindal RD Vasko RC Jr Jennings JR | 2008 | Am J Geriatr Psychiatry2008，16，11： | 1 |
| 12 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention:a randomised,double-blind,placebo-controlled phase II study显示文摘 | Becker RC Moliterno DJ Jennings LK | 2009 | Lancet2009，373，9667： | 1 |
| 13 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention显示文摘 | Becker RC Molitemo DJ Jennings LK | 2009 | Lancet2009，373，9667： | 1 |
| 14 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, plaeeboeon- trolled phase II study显示文摘 | Becker RC Molitemo D J Jennings 1K | 2009 | Lancet2009，373，9667： | 1 |
| 15 | 炎症细胞因子水平升高能预测特发性和家族性肺动脉高压患者的生存率显示文摘炎症是肺动脉高压(pulmonary arterial hyperten-sion,PAH)的特征之一,已有报道显示PAH患者循环中细胞因子的水平升高。但是,迄今为止,还没有细胞因子升高的重要性或者将细胞因子作为生物标志物潜在可能性的有关资料。研究者旨在确定PAH患者中一系列细胞因子的水平,并且检验这些细胞因子对患者生存率的影响以及它们与血流动力学指数的关系。 | 张玲玉 叶鹏 Soon E Holmes AM Treacy CM Doughty NJ Southgate L Machado RD Trem-bath RC Jennings S Barker L Nicklin P Walker C Budd DC Pepke-Zaba J Morrell NW | 2010 | 中华高血压杂志2010，18，12： | 1 |
| 16 | Safe- ty and tolerability of SCH530348 in patients undergoing non - urgent percutaneous coronary intervention 显示文摘 | Becker RC Moliterno D J Jennings LK | 2009 | Lancet2009，373，9667： | 1 |
| 17 | A new sesquiterpene lactone from Elephantopus scaber显示文摘 | Silva LB Herath WHMW Jennings RC | 1982 | Phytochemistry1982，21，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员